Sunday, January 18, 2026
News Health

News Health

Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk in individuals with schizophrenia spectrum disorders compared with placebo. Medscape Medical News Source link : https://www.medscape.com/viewarticle/semaglutide-lowers-antipsychotic-related-cardiometabolic-2025a1000yxa?src=rss Author...

Read more
Page 60 of 165 1 59 60 61 165

Categories

Archives

January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031